Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

North Central Cancer Treatment Group

Cancer and Leukemia Group B

NCIC Clinical Trials Group

Southwest Oncology Group

Information provided by (Responsible Party):

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00324805

First received: May 10, 2006

Last updated: March 3, 2015

Last verified: February 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2018 (Final data collection date for primary outcome measure)